NVZMY Novonesis (Novozymes) B ADR Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
14:46
Aug 20
Alex Morgan Bloomberg Reporter Bloomberg Markets
Raised guidance and buyback lift Novonesis.
Novonesis raised its full-year outlook and announced a major share buyback, helped by dairy and high-protein product demand, sending the stock sharply higher.
NVZMY 1ST
MED
04:18
Feb 18
A price target decrease from a major bank like JPMorgan signals a bearish outlook and potential.
A price target decrease from a major bank like JPMorgan signals a bearish outlook and potential for underperformance.
NVZMY
MED

About NVZMY Analyst Coverage

Buzzberg tracks NVZMY (Novonesis (Novozymes) B ADR) across 2 sources. 1 bullish vs 0 bearish calls from 2 analysts. Sentiment: predominantly bullish (50%). 2 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Alex Morgan, @FirstSquawk.